These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3484967)

  • 21. Weight-loss induced changes in plasma factor VII coagulant activity and relation to the factor VII Arg/Gln353 polymorphism in moderately obese adults.
    Pankow JS; Folsom AR; Shahar E; Tsai MY; Jeffery RW; Wing RR
    Thromb Haemost; 1998 Apr; 79(4):784-9. PubMed ID: 9569193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.
    Nakagaki T; Foster DC; Berkner KL; Kisiel W
    Biochemistry; 1991 Nov; 30(45):10819-24. PubMed ID: 1932002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study.
    Miller GJ; Stirling Y; Esnouf MP; Heinrich J; van de Loo J; Kienast J; Wu KK; Morrissey JH; Meade TW; Martin JC
    Thromb Haemost; 1994 Jan; 71(1):38-48. PubMed ID: 8165645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary fatty acids and blood coagulation.
    Miller GJ
    Prostaglandins Leukot Essent Fatty Acids; 1997 Oct; 57(4-5):389-94. PubMed ID: 9430384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor VII, cholesterol, and triglycerides. The CARDIA Study. Coronary Artery Risk Development in Young Adults Study.
    Green D; Chamberlain MA; Ruth KJ; Folsom AR; Liu K
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):51-5. PubMed ID: 9012637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men.
    Rao AK; Chouhan V; Chen X; Sun L; Boden G
    Diabetes; 1999 May; 48(5):1156-61. PubMed ID: 10331423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients.
    van Geffen M; Mathijssen NC; Holme PA; Laros-van Gorkom BA; van Kraaij MG; Masereeuw R; Peyvandi F; van Heerde WL
    Thromb Res; 2013 Jul; 132(1):116-22. PubMed ID: 23731565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of hormone replacement therapy of the age-related rise of factor VIIc, and its activity state.
    Wright D; Poller L; Thomson JM; Burrows GE; Hirst CF; Sidebotham A
    Thromb Res; 1997 Mar; 85(6):455-64. PubMed ID: 9101638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The activation of the contact phase of coagulation by physiologic surfaces in plasma: the effect of large negatively charged liposomal vesicles.
    Mitropoulos KA; Martin JC; Reeves BE; Esnouf MP
    Blood; 1989 May; 73(6):1525-33. PubMed ID: 2713491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes; the GUSTO-IIb haemostasis substudy.
    Kottke-Marchant K; Bahit MC; Granger CB; Zoldhelyi P; Ardissino D; Brooks L; Griffin JH; Potthoff RF; Van de Werf F; Califf RM; Topol EJ
    Eur Heart J; 2002 Aug; 23(15):1202-12. PubMed ID: 12127922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
    Hattori T; Khan MM; Colman RW; Edmunds LH
    J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a coagulation assay determining the activity state of factor VII in plasma.
    van Deijk WA; van Dam-Mieras MC; Muller AD; Hemker HC
    Haemostasis; 1983; 13(3):192-7. PubMed ID: 6604003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
    Gerotziafas GT; Chakroun T; Depasse F; Arzoglou P; Samama MM; Elalamy I
    Thromb Haemost; 2004 May; 91(5):977-85. PubMed ID: 15116259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma.
    Scharling B; Nielsen GG; Klitgaard T; Skovsted TA; Møss J; Segel S; Larsen LF
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):677-84. PubMed ID: 17890956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher concentrations of heparin and hirudin are required to inhibit thrombin generation in tissue factor-activated cord plasma than in adult plasma.
    Baier K; Cvirn G; Fritsch P; Köstenberger M; Gallistl S; Leschnik B; Muntean W
    Pediatr Res; 2005 May; 57(5 Pt 1):685-9. PubMed ID: 15718352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-decalcified barium sulfate-adsorbed plasma. A potentially useful reagent for studying blood clotting, platelets or complement.
    Zucker MB; Owen J
    Thromb Haemost; 1982 Apr; 47(2):182-4. PubMed ID: 6808695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction.
    Wildgoose P; Foster D; Schiødt J; Wiberg FC; Birktoft JJ; Petersen LC
    Biochemistry; 1993 Jan; 32(1):114-9. PubMed ID: 8418832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue factor interactions with factor VII: measurement and clinical significance of factor VIIa in plasma.
    Morrissey JH
    Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S14-9. PubMed ID: 7647216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombin activity by intrinsic activation of plasma in-vitro accelerates with increasing age of the donor.
    Ibbotson SH; Tate GM; Davies JA
    Thromb Haemost; 1992 Mar; 67(3):377-80. PubMed ID: 1641829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: relation to the development of cardiovascular disease.
    Kelleher CC
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):392-5. PubMed ID: 2196811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.